The Use Of A Multidrug Pill In Reducing Cardiovascular Events (UMPIRE) Trial
Funder
National Health and Medical Research Council
Funding Amount
$314,535.00
Summary
Patients who have cardiovascular disease are at very high risk of experiencing a heart attack or stroke, and current guidelines recommend the long-term use of aspirin, blood pressure lowering drugs and a cholesterol lowering drug in such patients to reduce their risks. The proposed research will investigate whether the availability of a polypill (a single pill containing all these drugs) will help ensure patients are appropriately prescribed these treatments, and keep taking them long-term. Aust ....Patients who have cardiovascular disease are at very high risk of experiencing a heart attack or stroke, and current guidelines recommend the long-term use of aspirin, blood pressure lowering drugs and a cholesterol lowering drug in such patients to reduce their risks. The proposed research will investigate whether the availability of a polypill (a single pill containing all these drugs) will help ensure patients are appropriately prescribed these treatments, and keep taking them long-term. Australian researchers will have a pivotal role in collecting and interpreting the data in this trial. In addition, Australian researchers will combine the findings of this study with results from similar trials being conducted in Australia (1600 patients, including 600 Aboriginal participants) and New Zealand (600 patients, including 600 Maori participants). This overview will provide very accurate information about the usefulness of the polypill, and how it should be used worldwide.Read moreRead less
Provision Of Secondary Cardiac Preventive Australian General Practice
Funder
National Health and Medical Research Council
Funding Amount
$499,513.00
Summary
This study will provide a comprehensive description of secondary preventative activities for patients with ischaemic heart disease, with the aim of determining those factors that can most contribute to reducing the increased risk of further events which they experience, and thereby reducing the burden of this disease.
A link between periodontal disease, inflammation of the gums, and cardiovascular disease has been suggested in recent studies, however the evidence remains uncertain. Supporting the link are data that inflammation predisposes to atherosclerosis and heart attacks. Patients in the PERICAR study will have blood tests before and after periodontal treatment so that researchers can study whether treatment reduces factors in the blood that have previously been shown to indicate the risk of cardiovascul ....A link between periodontal disease, inflammation of the gums, and cardiovascular disease has been suggested in recent studies, however the evidence remains uncertain. Supporting the link are data that inflammation predisposes to atherosclerosis and heart attacks. Patients in the PERICAR study will have blood tests before and after periodontal treatment so that researchers can study whether treatment reduces factors in the blood that have previously been shown to indicate the risk of cardiovascular disease. This study will provide further clues to this potentially very important and treatable relationship.Read moreRead less
Validation And Replication Of Genes Associated With Common Human Disease Using Australian Twin Families
Funder
National Health and Medical Research Council
Funding Amount
$921,224.00
Summary
The European Network for Genetic and Genomic Epidemiology (ENGAGE) aims to translate the wealth of data emerging from large-scale research efforts in molecular epidemiology into information of direct relevance to future advances in clinical medicine. ENGAGE will do this through the integration of very large datasets already available from a substantial number of large and well-characterised samples. The resulting ENGAGE resource will represent a research investment >€100M (>AU$160M) and pr ....The European Network for Genetic and Genomic Epidemiology (ENGAGE) aims to translate the wealth of data emerging from large-scale research efforts in molecular epidemiology into information of direct relevance to future advances in clinical medicine. ENGAGE will do this through the integration of very large datasets already available from a substantial number of large and well-characterised samples. The resulting ENGAGE resource will represent a research investment >€100M (>AU$160M) and provide unprecedented power to discover disease and trait susceptibility genes. QIMR will contribute 12,000 twins for ENGAGE joint analyses and provide analytical expertise in the analysis of disease and genetic data related to lifestyle and metabolic traits, with particular emphasis on cardiovascular disease, type 2 diabetes and migraine risk factors. Our laboratory will also perform vital further genetic studies to establish the causal relationship between the genetic variants concerned and the traits of interest. Most importantly, our direct participation will allow the translation of these findings into the Australian population and clinical arena.Read moreRead less
A National Resource For Mouse Models Of Mesothelioma
Funder
National Health and Medical Research Council
Funding Amount
$483,643.00
Summary
Mouse models of mesothelioma have led to a greater understanding of the disease and the identification of potential drug therapies some of these have now been translated into clinical trials. In the existing models, mesothelioma cells that have been grown in the laboratory are transplanted into animals by injecting the cells under the skin. Different cell lines with different properties are used in different experimental protocols. This application will fund the establishment of a central resour ....Mouse models of mesothelioma have led to a greater understanding of the disease and the identification of potential drug therapies some of these have now been translated into clinical trials. In the existing models, mesothelioma cells that have been grown in the laboratory are transplanted into animals by injecting the cells under the skin. Different cell lines with different properties are used in different experimental protocols. This application will fund the establishment of a central resource to maintain and distribute these cell lines. In addition, we describe a new transgenic mouse model in which mesotheliomas are rapidly induced in the peritoneal cavity after exposure to asbestos, recreating the natural tumour development much more accurately. These mice have been engineered to express the cancer causing protein of a monkey virus (SV40 large T antigen) in their mesothelial cells because it has been suggested that the virus has a role in the development of mesothelioma. This application also seeks funding to use the MexTAg mice to test the usefulness of different therapies for the prevention or treatment of mesothelioma. These animals give us the ability to investigate the disease in a more realistic environment than previous models. In parallel collaborative studies with other groups investigating different aspects of the biology of this cancer, we plan to analyze the earliest changes in the development of the disease and search for early markers using proteomics and gene expression studies. We anticipate that this model will generate information more directly relevant to understanding the human disease and will provide essential experimental data for clinical trials.Read moreRead less